Alzamend Neuro, Inc.
Pharmaceutical Preparations · ATLANTA · GA
Moderate confidence (50%)
Updated Oct 20, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Alzamend Neuro, Inc. received a delisting notice from its exchange (Aug 3, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Alzamend Neuro, Inc. received a delisting notice from its exchange
Aug 3, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 20, 2026, the Company notified Nasdaq that it was not in compliance with the majority independent board standard under Nasdaq Listing Rule 5605(b)(1) which requires listed companies to have a majority of the board of directors be comprised of Independent Directors (as defined in Nasdaq Listing Rule 5605(a)(2)) (the Majority Independent Board Standard ). As previously disclosed by the Company in its Current Report on Form 8-K filed on July 21, 2026 with the Securities and Excha…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker ALZN on Nasdaq.
- SEC CIK
- 0001677077
- Website
- —
- —
- Headquarters
- ATLANTA, GA
- Also known as
- —
- Legal entities
- Alzamend Neuro, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Alzamend Neuro, Inc. — Pharmaceutical Preparations (SIC 2834) — ATLANTA, GA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 20, 2026, the Company notified Nasdaq that it was not in compliance with the majority independent board standard under Nasdaq Listing Rule 5605(b)(1) which requires listed companies to have a majority of the board of directors be comprised of Independent Directors (as defined in Nasdaq Listing Rule 5605(a)(2)) (the Majority Independent Board Standard ). As previously disclosed by the Company in its Current Report on Form 8-K filed on July 21, 2026 with the Securities and Excha…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:27 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.